BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34912824)

  • 1. Metabolomic Profiling of Amino Acids in Human Plasma Distinguishes Diabetic Kidney Disease From Type 2 Diabetes Mellitus.
    Zhou C; Zhang Q; Lu L; Wang J; Liu D; Liu Z
    Front Med (Lausanne); 2021; 8():765873. PubMed ID: 34912824
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolomic profiling of amino acids study reveals a distinct diagnostic model for diabetic kidney disease.
    Wang J; Zhou C; Zhang Q; Liu Z
    Amino Acids; 2023 Nov; 55(11):1563-1572. PubMed ID: 37736814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
    Zhu H; Bai M; Xie X; Wang J; Weng C; Dai H; Chen J; Han F; Lin W
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry.
    Lin HT; Cheng ML; Lo CJ; Lin G; Liu FC
    Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma profiling of amino acids distinguishes acute gout from asymptomatic hyperuricemia.
    Luo Y; Wang L; Liu XY; Chen X; Song YX; Li XH; Jiang C; Peng A; Liu JY
    Amino Acids; 2018 Nov; 50(11):1539-1548. PubMed ID: 30073607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UPLC-MS-based urine nontargeted metabolic profiling identifies dysregulation of pantothenate and CoA biosynthesis pathway in diabetic kidney disease.
    Ma T; Liu T; Xie P; Jiang S; Yi W; Dai P; Guo X
    Life Sci; 2020 Oct; 258():118160. PubMed ID: 32730837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease.
    Liu JJ; Ghosh S; Kovalik JP; Ching J; Choi HW; Tavintharan S; Ong CN; Sum CF; Summers SA; Tai ES; Lim SC
    Kidney Int Rep; 2017 May; 2(3):470-480. PubMed ID: 29142974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic Investigation of Blood and Urinary Amino Acids and Derivatives in Patients with Type 2 Diabetes Mellitus and Early Diabetic Kidney Disease.
    Mogos M; Socaciu C; Socaciu AI; Vlad A; Gadalean F; Bob F; Milas O; Cretu OM; Suteanu-Simulescu A; Glavan M; Ienciu S; Balint L; Jianu DC; Petrica L
    Biomedicines; 2023 May; 11(6):. PubMed ID: 37371622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolite Profiling of the Gut-Renal-Cerebral Axis Reveals a Particular Pattern in Early Diabetic Kidney Disease in T2DM Patients.
    Balint L; Socaciu C; Socaciu AI; Vlad A; Gadalean F; Bob F; Milas O; Cretu OM; Suteanu-Simulescu A; Glavan M; Ienciu S; Mogos M; Jianu DC; Petrica L
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine metabolomics reveals biomarkers and the underlying pathogenesis of diabetic kidney disease.
    Luo M; Zhang Z; Lu Y; Feng W; Wu H; Fan L; Guan B; Dai Y; Tang D; Dong X; Yun C; Hocher B; Liu H; Li Q; Yin L
    Int Urol Nephrol; 2023 Apr; 55(4):1001-1013. PubMed ID: 36255506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC/MS-based discrimination between plasma and urine metabolomic changes following exposure to ultraviolet radiation by using data modelling.
    Ali AM; Monaghan C; Muggeridge DJ; Easton C; Watson DG
    Metabolomics; 2023 Feb; 19(2):13. PubMed ID: 36781606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly.
    Pan F; Cui W; Gao L; Shi X; Yang H; Hu Y; Li M
    J Clin Lab Anal; 2022 Apr; 36(4):e24350. PubMed ID: 35293029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipidomics Profiling Reveals Serum Phospholipids Associated with Albuminuria in Early Type 2 Diabetic Kidney Disease.
    Ye S; Hu YP; Zhou Q; Zhang H; Xia ZZ; Zhao SZ; Wang Z; Wang SY; Wang XY; Zhang YK; Chen ZD; Mao GY; Zheng C
    ACS Omega; 2023 Oct; 8(39):36543-36552. PubMed ID: 37810655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
    Zhang M; Zhao B; Xie J; Liang Y; Yang Z
    Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles metabolic changes reveals plasma signature in stage-dependent diabetic kidney disease.
    Pan Y; Yang H; Chen T; Jin J; Ruan L; Hu L; Chen L
    Ren Fail; 2022 Dec; 44(1):1840-1849. PubMed ID: 36368309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry.
    Tsutsui H; Maeda T; Min JZ; Inagaki S; Higashi T; Kagawa Y; Toyo'oka T
    Clin Chim Acta; 2011 May; 412(11-12):861-72. PubMed ID: 21185819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
    Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
    Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic profiling and correlations with clinical features reveal biomarkers indicative of diabetic retinopathy with diabetic kidney disease.
    Fan X; Xu M; Chen X; Ren Q; Fan Y; Wang R; Chen J; Cui L; Wang Z; Sun X; Guo N
    Front Endocrinol (Lausanne); 2022; 13():1001391. PubMed ID: 36277688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino Acid Signature of Oxidative Stress in Patients with Type 2 Diabetes: Targeted Exploratory Metabolomic Research.
    Bala CG; Rusu A; Ciobanu D; Bucsa C; Roman G
    Antioxidants (Basel); 2021 Apr; 10(4):. PubMed ID: 33921149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.